Significance of S-phase fraction and hormone receptor content in the management of young breast cancer patients
- 1 October 1992
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 66 (4) , 706-711
- https://doi.org/10.1038/bjc.1992.342
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Proliferative activity, histological grade and benefit from adjuvant chemotherapy in node positive breast cancerEuropean Journal of Cancer and Clinical Oncology, 1990
- Indicators of Prognosis in Node-Negative Breast CancerNew England Journal of Medicine, 1990
- Prognostic value of estrogen and progesterone receptors in primary infiltrating ductal breast cancerEuropean Journal of Cancer and Clinical Oncology, 1989
- Cell kinetics as a prognostic indicator in node-negative breast cancerEuropean Journal of Cancer and Clinical Oncology, 1989
- Prediction of Relapse or Survival in Patients with Node-Negative Breast Cancer by DNA Flow CytometryNew England Journal of Medicine, 1989
- A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive TumorsNew England Journal of Medicine, 1989
- Prognostic value of DNA ploidy and S-phase fraction in relation to estrogen receptor content and clinicopathological variables in primary breast cancerEuropean Journal of Cancer and Clinical Oncology, 1989
- Proliferative index of breast carcinoma by thymidine labeling: Prognostic power independent of stage, estrogen and progesterone receptorsBreast Cancer Research and Treatment, 1988
- The DNA labelling index: A prognostic factor in node-negative breast cancerBreast Cancer Research and Treatment, 1987
- Estrogen receptor status as a prognostic indicator for stage I breast cancer patientsBreast Cancer Research and Treatment, 1982